Toxicologists employ several strategies to address variability in biological responses. One approach is the use of biomarkers to identify susceptible individuals and populations. Additionally, advanced modeling techniques, such as physiologically based pharmacokinetic models, allow for more accurate predictions of chemical behavior in diverse populations. Incorporating population-specific data into risk assessments can enhance the precision and relevance of safety guidelines.
